Median Technologies has received CE marking for its eyonis LCS, an AI-based Software as a Medical Device, under the European Medical Device Regulation (MDR 2017/745).

The designation enables the company to commercialise eyonis LCS across the European Economic Area.

The CE marking was granted by the French notified body GMED, recognising the device as compliant with the regulatory standards for patient safety and clinical efficacy required for a Class IIb medical device.